Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

BACKGROUND: Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be only limitedly explored further for causation because of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807419/
https://www.ncbi.nlm.nih.gov/pubmed/36593440
http://dx.doi.org/10.1186/s12874-022-01760-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807419/
https://www.ncbi.nlm.nih.gov/pubmed/36593440
http://dx.doi.org/10.1186/s12874-022-01760-0

Ejemplares similares